4.4 Article

Identification of TP53 as an acute lymphocytic leukemia susceptibility gene through exome sequencing

Journal

PEDIATRIC BLOOD & CANCER
Volume 60, Issue 6, Pages E1-E3

Publisher

WILEY-BLACKWELL
DOI: 10.1002/pbc.24417

Keywords

acute lymphocytic leukemia; exome sequencing; genetic predisposition to disease; genetic testing

Funding

  1. Cancer Prevention and Research Institute of Texas [RP10189]
  2. National Cancer Institute [R01 CA138836]
  3. National Institute of General Medical Sciences [T32 GM007526]

Ask authors/readers for more resources

Although acute lymphocytic leukemia (ALL) is the most common childhood cancer, genetic predisposition to ALL remains poorly understood. Whole-exome sequencing was performed in an extended kindred in which five individuals had been diagnosed with leukemia. Analysis revealed a nonsense variant of TP53 which has been previously reported in families with sarcomas and other typical Li Fraumeni syndrome-associated cancers but never in a familial leukemia kindred. This unexpected finding enabled identification of an appropriate sibling bone marrow donor and illustrates that exome sequencing will reveal atypical clinical presentations of even well-studied genes. Pediatr Blood Cancer 2013; 60: E1E3. (c) 2012 Wiley Periodicals, Inc.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available